Chevilly-Larue, France

Mathilde Boulpicante

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Mathilde Boulpicante in Cancer Treatment

Introduction: Mathilde Boulpicante, an accomplished inventor based in Chevilly-Larue, France, has made significant strides in the field of medicine, particularly in cancer treatment. Her innovative work has culminated in the development of a groundbreaking patent that has the potential to change the landscape of cancer therapy.

Latest Patents: Mathilde holds a patent for "Compounds, Composition and Uses Thereof for Treating Cancer." This invention relates specifically to new compounds designed to function as a medicament. The patent focuses on enhancing the presentation of Pioneer Translation Products (PTPs)-derived antigens by cancer cells in a subject, as well as inducing an immune response. It outlines methods for preventing or treating cancer, cancer metastasis, and cancer recurrence, thereby contributing valuable tools for improving cancer therapies. Additionally, the patent includes kits for preparing pharmaceutical compositions that facilitate the application of these methods.

Career Highlights: Mathilde Boulpicante is affiliated with the Institut Gustave Roussy, which is renowned for its dedication to cancer research and treatment. Her work involves exploring innovative approaches to combatting cancer, showcasing her commitment to advancing medical science and patient care.

Collaborations: Throughout her career, Mathilde has collaborated with esteemed colleagues such as Sébastien Apcher and Alison Pierson. Together, they contribute to the advancement of cancer treatment methodologies, demonstrating a collaborative spirit that enhances research outcomes.

Conclusion: Mathilde Boulpicante stands out as a notable inventor in the realm of cancer treatment with her patent for novel compounds aimed at improving therapeutic efficacy. Her contributions through the Institut Gustave Roussy and her collaborations reflect her dedication to innovation in medicine. As research in this field progresses, her work may leave a lasting impact on cancer care and patient survival.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…